Pten is essential for embryonic development and tumour suppression

The PTEN gene encodes a dual-specificity phosphatase mutated in a variety of human cancers. PTEN germline mutations are found in three related human autosomal dominant disorders, Cowden disease (CD), Lhermitte-Duclos disease (LDD) and Bannayan-Zonana syndrome (BZS), characterized by tumour susceptibility and developmental defects. To examine the role of PTEN in ontogenesis and tumour suppression, we disrupted mouse Pten by homologous recombination. Pten inactivation resulted in early embryonic lethality. Pten–/– ES cells formed aberrant embryoid bodies and displayed an altered ability to differentiate into endodermal, ectodermal and mesodermal derivatives. Pten+/– mice and chimaeric mice derived from Pten+/– ES cells showed hyperplastic-dysplastic changes in the prostate, skin and colon, which are characteristic of CD, LDD and BZS. They also spontaneously developed germ cell, gonadostromal, thyroid and colon tumours. In addition, Pten inactivation enhanced the ability of ES cells to generate tumours in nude and syngeneic mice, due to increased anchorage-independent growth and aberrant differentiation. These results support the notion that PTEN haploinsufficiency plays a causal role in CD, LDD and BZS pathogenesis, and demonstrate that Pten is a tumour suppressor essential for embryonic development.

[1]  D. Wechsler,et al.  Localization of the human Mxi1 transcription factor gene (MXI1) to chromosome 10q24-q25. , 1994, Genomics.

[2]  R. Bronson,et al.  Neonatal lethality and lymphopenia in mice with a homozygous disruption of the c-abl proto-oncogene , 1991, Cell.

[3]  L. Chin,et al.  Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.

[4]  A. Elefanty,et al.  Hematopoietic-specific genes are not induced during in vitro differentiation of scl-null embryonic stem cells. , 1997, Blood.

[5]  L. Aaltonen,et al.  Mutations in the SMAD4/DPC4 gene in juvenile polyposis. , 1998, Science.

[6]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[7]  Bannayan Ga.  Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. , 1971 .

[8]  Hiroyuki Miyoshi,et al.  Intestinal Tumorigenesis in Compound Mutant Mice of both Dpc4(Smad4) and Apc Genes , 1998, Cell.

[9]  W. Cavenee,et al.  Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[10]  K. Kinzler,et al.  Landscaping the Cancer Terrain , 1998, Science.

[11]  R. Vessella,et al.  Inactivation of the tumor suppressor PTEN/MMAC1 in advanced human prostate cancer through loss of expression. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[12]  A. Berchuck,et al.  PTEN/MMAC1 mutations in endometrial cancers. , 1997, Cancer research.

[13]  P. Guldberg,et al.  Disruption of the MMAC1/PTEN gene by deletion or mutation is a frequent event in malignant melanoma. , 1997, Cancer research.

[14]  D. Rimoin,et al.  Macrocephaly with multiple lipomas and hemangiomas. , 1976, The Journal of pediatrics.

[15]  P. Goodfellow,et al.  A comparison of the properties of Sox-3 with Sry and two related genes, Sox-1 and Sox-2. , 1996, Development.

[16]  Jing Li,et al.  Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome , 1997, Nature Genetics.

[17]  J. Rossant,et al.  The tumor suppressor gene Smad4/Dpc4 is required for gastrulation and later for anterior development of the mouse embryo. , 1998, Genes & development.

[18]  W. K. Alfred Yung,et al.  Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers , 1997, Nature Genetics.

[19]  S. Seal,et al.  Cowden syndrome and Lhermitte-Duclos disease in a family: a single genetic syndrome with pleiotropy? , 1994, Journal of medical genetics.

[20]  D. Barford,et al.  Protein tyrosine phosphatases take off , 1995, Nature Structural Biology.

[21]  M. Wiles,et al.  Hematopoietic commitment during embryonic stem cell differentiation in culture. , 1993, Molecular and cellular biology.

[22]  W. Isaacs,et al.  Interfocal heterogeneity of PTEN/MMAC1 gene alterations in multiple metastatic prostate cancer tissues. , 1998, Cancer research.

[23]  G. Bannayan.  Lipomatosis, angiomatosis, and macrencephalia. A previously undescribed congenital syndrome. , 1971, Archives of pathology.

[24]  M. Wigler,et al.  PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.

[25]  M. Myers,et al.  PTEN: sometimes taking it off can be better than putting it on. , 1997, American journal of human genetics.

[26]  P. Pandolfi,et al.  Murine embryonic stem cells without pig-a gene activity are competent for hematopoiesis with the PNH phenotype but not for clonal expansion. , 1997, The Journal of clinical investigation.

[27]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[28]  B. Hogan,et al.  Bone morphogenetic protein-4 is required for mesoderm formation and patterning in the mouse. , 1995, Genes & development.

[29]  Arthur R. Brothman,et al.  Mutation of the MXI1 gene in prostate cancer , 1995, Nature Genetics.

[30]  M. Wiles.  Embryonic stem cell differentiation in vitro. , 1993, Methods in enzymology.

[31]  J. Darnell,et al.  Disruption of the HNF-4 gene, expressed in visceral endoderm, leads to cell death in embryonic ectoderm and impaired gastrulation of mouse embryos. , 1994, Genes & development.

[32]  R. Eeles,et al.  Allelic imbalance, including deletion of PTEN/MMAC1, at the Cowden disease locus on 10q22‐23, in hamartomas from patients with cowden syndrome and germline PTEN mutation , 1998, Genes, chromosomes & cancer.

[33]  G. Bots,et al.  Lhermitte‐duclos disease and cowden disease: A single phakomatosis , 1991, Annals of neurology.

[34]  R. Brent,et al.  Mapping of two genes encoding members of a distinct subfamily of MAX interacting proteins: MAD to human chromosome 2 and mouse chromosome 6, and MXI1 to human chromosome 10 and mouse chromosome 19. , 1994, Oncogene.

[35]  E. Coucouvanis,et al.  Signals for death and survival: A two-step mechanism for cavitation in the vertebrate embryo , 1995, Cell.

[36]  E. Prochownik,et al.  Assignment of the human MAD and MXI1 genes to chromosomes 2p12-p13 and 10q24-q25. , 1994, Genomics.

[37]  B. Burke,et al.  Bannayan-Riley-Ruvalcaba syndrome. , 1992, American journal of medical genetics.

[38]  C Eng,et al.  Mutation spectrum and genotype-phenotype analyses in Cowden disease and Bannayan-Zonana syndrome, two hamartoma syndromes with germline PTEN mutation. , 1998, Human molecular genetics.

[39]  J. Gerdes,et al.  Ki-67 immunoexpression is a robust marker of proliferative cells in the rat. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[40]  Kenneth M. Yamada,et al.  Inhibition of cell migration, spreading, and focal adhesions by tumor suppressor PTEN. , 1998, Science.

[41]  E. Robertson.  Teratocarcinomas and embryonic stem cells : a practical approach , 1987 .

[42]  R. DePinho,et al.  Role of Mxi1 in ageing organ systems and the regulation of normal and neoplastic growth , 1998, Nature.

[43]  M. Nelen,et al.  Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. , 1997, Human molecular genetics.

[44]  W. Schmid,et al.  Hepatocytic transcription factor expression in human embryonal carcinoma and yolk sac carcinoma cell lines: expression of HNF-3 alpha in models of early endodermal cell differentiation. , 1994, Experimental cell research.